279 related articles for article (PubMed ID: 21276079)
1. Coexistence of TDP-43 and tau pathology in neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome).
Haraguchi T; Terada S; Ishizu H; Yokota O; Yoshida H; Takeda N; Kishimoto Y; Katayama N; Takata H; Akagi M; Kuroda S; Ihara Y; Uchitomi Y
Neuropathology; 2011 Oct; 31(5):531-9. PubMed ID: 21276079
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies.
Neumann M; Adler S; Schlüter O; Kremmer E; Benecke R; Kretzschmar HA
Acta Neuropathol; 2000 Nov; 100(5):568-74. PubMed ID: 11045680
[TBL] [Abstract][Full Text] [Related]
3. Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and lewy body pathology.
Wakabayashi K; Fukushima T; Koide R; Horikawa Y; Hasegawa M; Watanabe Y; Noda T; Eguchi I; Morita T; Yoshimoto M; Iwatsubo T; Takahashi H
Acta Neuropathol; 2000 Mar; 99(3):331-6. PubMed ID: 10663979
[TBL] [Abstract][Full Text] [Related]
4. Tau-predominant-associated pathology in a sporadic late-onset Hallervorden-Spatz syndrome.
Zarranz JJ; Gómez-Esteban JC; Atarés B; Lezcano E; Forcadas M
Mov Disord; 2006 Jan; 21(1):107-11. PubMed ID: 16114023
[TBL] [Abstract][Full Text] [Related]
5. Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology.
Galvin JE; Giasson B; Hurtig HI; Lee VM; Trojanowski JQ
Am J Pathol; 2000 Aug; 157(2):361-8. PubMed ID: 10934140
[TBL] [Abstract][Full Text] [Related]
6. Dementia means number of things - the overlap of neurodegeneration with brain iron accumulation (NBIA) and Alzheimer changes: an autopsy case.
Dziewulska D; Domitrz I; Domzał-Stryga A
Folia Neuropathol; 2010; 48(2):129-33. PubMed ID: 20602294
[TBL] [Abstract][Full Text] [Related]
7. Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.
Clement F; Devos D; Moreau C; Coubes P; Destee A; Defebvre L
Acta Neurol Belg; 2007 Mar; 107(1):26-31. PubMed ID: 17569231
[TBL] [Abstract][Full Text] [Related]
8. Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course.
Saito Y; Kawai M; Inoue K; Sasaki R; Arai H; Nanba E; Kuzuhara S; Ihara Y; Kanazawa I; Murayama S
J Neurol Sci; 2000 Aug; 177(1):48-59. PubMed ID: 10967182
[TBL] [Abstract][Full Text] [Related]
9. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.
Arawaka S; Saito Y; Murayama S; Mori H
Neurology; 1998 Sep; 51(3):887-9. PubMed ID: 9748051
[TBL] [Abstract][Full Text] [Related]
10. Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism.
Jankovic J; Kirkpatrick JB; Blomquist KA; Langlais PJ; Bird ED
Neurology; 1985 Feb; 35(2):227-34. PubMed ID: 3969211
[TBL] [Abstract][Full Text] [Related]
11. Neurodegeneration with brain iron accumulation: A cautionary tale.
Pearce JM
Eur Neurol; 2006; 56(1):66-8. PubMed ID: 16921248
[TBL] [Abstract][Full Text] [Related]
12. Genetics of neurodegeneration with brain iron accumulation.
Gregory A; Hayflick SJ
Curr Neurol Neurosci Rep; 2011 Jun; 11(3):254-61. PubMed ID: 21286947
[TBL] [Abstract][Full Text] [Related]
13. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
Thomas M; Hayflick SJ; Jankovic J
Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
[TBL] [Abstract][Full Text] [Related]
14. Pantothenate kinase-associated neurodegeneration is not a synucleinopathy.
Li A; Paudel R; Johnson R; Courtney R; Lees AJ; Holton JL; Hardy J; Revesz T; Houlden H
Neuropathol Appl Neurobiol; 2013 Feb; 39(2):121-31. PubMed ID: 22416811
[TBL] [Abstract][Full Text] [Related]
15. Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity.
Eidelberg D; Sotrel A; Joachim C; Selkoe D; Forman A; Pendlebury WW; Perl DP
Brain; 1987 Aug; 110 ( Pt 4)():993-1013. PubMed ID: 2888513
[TBL] [Abstract][Full Text] [Related]
16. Autopsy always teach and tell: neurodegeneration with brain iron accumulation: a case report.
Gupta R; Kumar A; Sharma MC; Sarkar C; Goyal V; Bihari M
Indian J Pathol Microbiol; 2007 Oct; 50(4):792-4. PubMed ID: 18306557
[TBL] [Abstract][Full Text] [Related]
17. Hallervorden-Spatz disease in an adult patient.
Dymecki J; Bertrand E; Tomankiewicz Z; Szuniewicz H
Folia Neuropathol; 1999; 37(4):235-8. PubMed ID: 10705643
[TBL] [Abstract][Full Text] [Related]
18. Adult-onset neurodegeneration with brain iron accumulation and cortical alpha-synuclein and tau pathology: a distinct clinicopathological entity.
Tofaris GK; Revesz T; Jacques TS; Papacostas S; Chataway J
Arch Neurol; 2007 Feb; 64(2):280-2. PubMed ID: 17296847
[TBL] [Abstract][Full Text] [Related]
19. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.
Hayflick SJ; Hartman M; Coryell J; Gitschier J; Rowley H
AJNR Am J Neuroradiol; 2006; 27(6):1230-3. PubMed ID: 16775270
[TBL] [Abstract][Full Text] [Related]
20. Sporadic late-onset Hallervorden-Spatz disease presenting as parkinsonism in a Chinese patient.
Wang LN; Huang KW; Liu ZY
Chin Med J (Engl); 1990 Aug; 103(8):686-8. PubMed ID: 2122948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
